6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
11m ago	GDS Files 2025 Annual Report on Form 20-F
12m ago	Diana Shipping Inc. Announces Time Charter Contracts for m/v New York with Refined Success and m/v DSI Pyxis with Oldendorff
12m ago	Merlin, Inc. Announces $80 Million PIPE Investment to Accelerate Program Execution and Unlock New Growth Opportunities
12m ago	Volta Finance Limited Net Asset Value(s) as at 31 March 2026
12m ago	Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Snapshot Recipes Redesign with Advanced AI, Beverage Integration, and Smart Cookbook Features

About

Xenon Pharmaceuticals Inc (NASDAQ:XENE) — investor relations, events, news, and company updates on 6ix.

Latest News

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting

Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering

Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)

Financials

Revenue

$7.5 M

Market Cap

$5.43 B

EPS

-4.36

Community Chat

Ask AI